Anticoagulant Drugs: Low-Molecular-Weight Heparins
Errors occurring during blood pressure monitoring
Venous Thrombosis III: Interprofessional Care
Pharmaceutical Poisoning: Potential Scenarios
Guidelines for Nursing Documentation I
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 23, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Marielle Slikkerveer1, Afke van de Plas1, Johanna H M Driessen
1From the Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center.
Prescribing errors for low-molecular-weight heparins (LMWHs) affect 34% of patients, often due to incorrect dosing based on weight and kidney function. Medical wards show higher error rates for LMWH prophylaxis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: